ScreenerHero

MVIR Medivir AB (publ)

STO · SE · Healthcare · Biotechnology · medivir.com
1.594SEK-5.46%Mkt Cap: 95.17M $P/E: —

Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationall…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap95.17M USD
Enterprise Value75.84M USD
Revenue (TTM)832.75K USD
Gross Profit-3.05M USD
Net Income (TTM)-9.03M USD
Revenue/Share0.03 SEK
Last Price1.594 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0020181014
Valuation
P/E (Trailing)—
P/E (Forward)-1.37
PEG0.74
EV/EBITDA-9.08
EV/Revenue91.07
P/S120.88
P/B3.52
EPS (TTM)-0.38
EPS (Forward)-1.23
52W Range
0.340049% of range2.885
52W High2.885 SEK
52W Low0.3400 SEK
Profitability
Gross Margin0.00%
Oper. Margin-1766.67%
EBITDA Margin0.00%
Profit Margin-1109.80%
ROE-60.82%
ROA-47.87%
Growth
Revenue Growth-20.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.02M USD
CapEx (TTM)—
FCF Margin-971.34%
FCF Yield-8.50%
Net Debt-23.82M USD
Net Debt/EBITDA2.85
Balance Sheet
Debt/Equity0.05
Current Ratio8.49
Quick Ratio8.49
Book Value/Sh0.48 SEK
Cash/Share0.41 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 9, 1996
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.212 SEK
Upside (mean)+227.0%
Target Range4.100 SEK – 6.937 SEK
4.100+227.0% to mean6.937
# Analysts3
Ownership
Shares Out.624.18M
Float344.98M
Insiders36.17%
Institutions15.52%
Technical
SMA 501.796 (-11.2%)
SMA 2001.618 (-1.5%)
Beta0.11
S&P 52W Chg14.58%
Avg Vol (30d)1.51M
Avg Vol (10d)1.50M
Technical Indicators
RSI (14)38.4
MACD-0.0544
MACD Signal-0.0462
MACD Hist.-0.0081
BB Upper1.892 SEK
BB Middle1.714 SEK
BB Lower1.536 SEK
BB Width20.80%
ATR (14)0.0865 SEK
Vol Ratio (20d)1.45x